Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
A common message emerging from the government enforcement agencies is that data analytics have been critical to fraud and…
From - G2 Compliance Advisor
The U.S. Health and Human Services Office of Inspector General released its mid-year update to the Annual Work Plan, adding and revising items relevant to…